Equity
€76,780 ▲ 31.2%
RERO has made a profit in every financial year since 2023.
RERO
Overview
Lifetime
3 annual accounts with figures on one time axispeak €45,845 (2023)
€40,036▼ 10.8%
peak €30,437 (2023)
€18,238▼ 27.4%
peak €76,780 (2025)
€76,780▲ 31.2%
€18,188▲ 14.6%
Board2 names since 2023
2 directorsDANIELS, Reine and 1 other
Documentsfilings and deeds
29-07-20262 days before the deadline
2025micro format
Result from €25,105 to €18,238Equity from €58,542 to €76,780
Key points
from the 2025 annual accountsChecked score
96
Excellent
Financially stronger than 71% of micro companies in human health (NACE 86)
Probability in this band: under 0.55%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%
The dashed line is the sector median: < 0.1% across 24,185 companies (NACE 86, micro).
Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
12-2024: 0.1%
01-2025: 0.1%● unchanged vs 12-2024
02-2025: 0.1%● unchanged vs 01-2025
03-2025: 0.1%● unchanged vs 02-2025
04-2025: 0.1%● unchanged vs 03-2025
05-2025: 0.1%● unchanged vs 04-2025
06-2025: 0.1%● unchanged vs 05-2025
07-2025: 0.1%● unchanged vs 06-2025highest value
08-2025: < 0.1%▼ -0.1 percentage points vs 07-2025lowest value
09-2025: < 0.1%● unchanged vs 08-2025lowest value
10-2025: < 0.1%● unchanged vs 09-2025lowest value
11-2025: < 0.1%● unchanged vs 10-2025lowest value
12-2025: < 0.1%● unchanged vs 11-2025lowest value
01-2026: < 0.1%● unchanged vs 12-2025lowest value
02-2026: < 0.1%● unchanged vs 01-2026
03-2026: < 0.1%● unchanged vs 02-2026
04-2026: < 0.1%● unchanged vs 03-2026
05-2026: < 0.1%● unchanged vs 04-2026
06-2026: < 0.1%● unchanged vs 05-2026
07-2026: < 0.1%● unchanged vs 06-2026
08-2026: < 0.1%● unchanged vs 07-2026
09-2026: < 0.1%● unchanged vs 08-2026
10-2026: < 0.1%● unchanged vs 09-2026
11-2026: < 0.1%● unchanged vs 10-2026
Financial strengthStrong
Score breakdown
lowers risk
Sector: Human health activities (NACE 86)
Liquidity: current ratio 5.19, cash €36,625
Figures for financial year 2025 (filed on 06-08-2026)
Equity €76,780 (80.8% of total assets)
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 82% of them on solvency, 81% on liquidity, 50% on profitability and 72% on growth.
The bankruptcy probability was computed on 09-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
The probability rests on the annual accounts with balance sheet date 31-12-2025.
Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Comparable companies, two years later
In July 2024, 39,278 companies had the same profile as RERO has now. Each dot stands for 99 companies, two years later.
95.8%
were still trading
2.3%
stopped another way
1.8%
went bankrupt
Another 0.1% stopped without a precise date, possibly only after those two years.
The bankruptcy probability of RERO itself is lower: < 0.1% within 12 months. It rests on far more data about RERO than the profile alone.
Test of the method
The method was tested on the 497,447 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 39,278 companies, not a prediction for RERO. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit of up to €7,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 5.19 (7.03 in 2024), above the usual 1.5. Short-term debt is 16.4% and cash 38.6% of total assets. 19.2% of the assets are financed with debt and provisions.
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
5 signals, none raises the risk
Five signals.
lowers riskneutral
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 29-07-2026, 2 days ahead of the deadline.
NBB · 3 filingsDeviation from the deadline
2025
2 days early
2024
31 days early
2023
78 days early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
The company filed its last 3 accounts on average 37 days before the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.
Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 30 June (3 of the last 3 accounts filed within 46 days either side of that date).
Companies Code · seven monthsWhere today falls in the filing period
10-11-2026 today31-12-2026 year end31-07-2027 deadline
Board and ownership
- ENGELEN, Roy Hendrik 15 sharesdeed of 20-06-2023
- DANIELS, Reine 15 sharesdeed of 20-06-2023
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0802826141
Incorporation
Founding capital of €3,000, 30 shares · Founders: ENGELEN, Roy Hendrik; DANIELS, Reine · Appointments: ENGELEN, Roy Hendrik (director) and DANIELS, Reine (director) · published on 20-06-2023 · Gazette deed
First establishment
Tessenderlosesteenweg 180, Beringen
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| RERO Beringen | €94,968 | €40,036 | 80.8% | - |
| Kine VDB Heusden-Zolder | €91,736 | €40,963 | 89.1% | - |
| HD Physio Beringen | €87,050 | €40,735 | 90.1% | - |
| KINE-OSTEO EBEN Genk | €91,773 | €44,372 | 71.2% | - |
| NEUROPELT Pelt | €85,371 | €37,241 | 55.0% | - |
| Dr. Laurens Van Melkebeke Haaltert | €97,254 | €40,305 | 63.5% | - |
| Physio2Perform Edegem | €93,128 | €39,010 | 7.5% | - |
These companies have the same main activity as RERO: physiotherapy (NACE 86951). They are comparable in size and age: total assets between €85,400 and €97,300, founded in 2023.
Official details
Source: KBO- Status
- Active since 16-06-2023Normal situation
- Activity
- PhysiotherapyNACE 86951and 1 other
- Establishment unit
- 2.346.598.1653583 Beringen, since 16-06-2023
- Financial year end
- 31 December
- Peppol
- Reachable since 21-12-2025
Annual accounts 2025
- €40,036▼ 10.8%
- €18,238▼ 27.4%
- €76,780▲ 31.2%
- €94,968▲ 27.6%
- Filing
- Filed on 29-07-2026, 2 days before the end of the filing period
Insights on RERO
RERO files the micro format. That format states no turnover. The gross margin fell from €45,845 in 2023 to €40,036 in 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette.
Financials
Annual accounts 2025
micro format, filed on 29-07-2026, 2 days before the deadline€40,036
▼ 10.8%
€30,725
▼ 15.7%
€18,238
▼ 27.4%
€65,442
▲ 28.3%
80.8%
▲ 2.2 percentage points
5.19
▼ 1.84
Turnover and EBIT margin are not published. The abbreviated or micro format does not require them. The turnover shown is an estimate from the gross margin.
Turnover ≈ €120,000. Estimated: probably between €92,000 and €170,000.
Balance sheet
balance sheet total €94,968 on 31-12-2025What the company ownsHow it is paid for
in euro
in euro
Position in the sector
80.8%
Higher than 71% of 20,767 companies in 2025.
5.19
Higher than 70% of 20,341 companies in 2025.
19.2%
Higher than 47% of 20,623 companies in 2025.
RERO
Middle half of the sector
80% of the sector
Micro accounts in human health (NACE 86)
Net result: bottom quarter · Equity: middle half · Balance sheet total: bottom quarter · Working capital: middle half
Filed annual accounts
as filed with the National Bank, click a year to choose it| Line | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Balance sheet: assets | ||||
20/58 |
94,968 | 74,416 | 57,957 | |
21/28 |
13,914 | 14,941 | 19,808 | |
22/27 |
13,914 | 14,941 | 19,808 | |
24 |
5,573 | 867 | - | |
25 |
8,341 | 14,074 | 19,808 | |
29/58 |
81,055 | 59,475 | 38,149 | |
29 |
17,902 | 17,902 | 17,902 | |
291 |
17,902 | 17,902 | 17,902 | |
40/41 |
26,020 | 4,305 | 13,862 | |
40 |
13,483 | 2,104 | 13,862 | |
41 |
12,537 | 2,202 | - | |
54/58 |
36,625 | 36,760 | 5,877 | |
490/1 |
508 | 508 | 508 | |
| Balance sheet: equity and liabilities | ||||
10/49 |
94,968 | 74,416 | 57,957 | |
10/15 |
76,780 | 58,542 | 33,437 | |
10/11 |
3,000 | 3,000 | 3,000 | |
13 |
73,780 | 55,542 | 30,437 | |
133 |
73,780 | 55,542 | 30,437 | |
17/49 |
18,188 | 15,874 | 24,520 | |
17 |
2,575 | 7,411 | 12,048 | |
170/4 |
2,575 | 7,411 | 12,048 | |
42/48 |
15,613 | 8,463 | 12,472 | |
42 |
4,836 | 4,636 | 4,445 | |
43 |
429 | 423 | - | |
430/8 |
429 | 423 | - | |
44 |
2,383 | 1,256 | 1,937 | |
440/4 |
2,383 | 1,256 | 1,937 | |
45 |
7,965 | 1,195 | 4,195 | |
450/3 |
3,941 | 1,195 | 1,195 | |
454/9 |
4,024 | 0 | 3,000 | |
47/48 |
0 | 953 | 1,895 | |
| Income statement | ||||
9900 |
40,036 | 44,888 | 45,845 | |
630 |
6,118 | 5,764 | 3,126 | |
640/8 |
3,194 | 2,671 | 2,725 | |
9901 |
30,725 | 36,454 | 39,995 | |
75/76B |
602 | 3 | 537 | |
75 |
602 | 3 | 537 | |
65/66B |
1,647 | 2,553 | 1,400 | |
65 |
1,647 | 2,553 | 1,400 | |
9903 |
29,679 | 33,903 | 39,132 | |
67/77 |
11,441 | 8,798 | 8,695 | |
9904 |
18,238 | 25,105 | 30,437 | |
9905 |
18,238 | 25,105 | 30,437 | |
| Appropriation of the result | ||||
9906 |
18,238 | 25,105 | 30,437 | |
691/2 |
18,238 | 25,105 | 30,437 | |
6920 |
18,238 | 25,105 | - | |
6921 |
- | - | 30,437 | |
| Document | ||||
The notes to these accounts have 15 items, including the statement of assets and debts, the cost breakdown and rights and commitments. You find them in the accounts filed with the NBB.
Source: Annual accounts 2025 at the NBB, filed on 29-07-2026.
Filings
each dot is a set of accounts, on the day it reached the National BankSubsidies and aid
Flemish government 2023 to 2025, 3 entries, €4,048 awarded, €4,042 paid
| Year | Entries | Awarded | Paid |
|---|---|---|---|
| 2025 | 1 | €1,244 | €1,244 |
| 2024 | 1 | €1,676 | €1,670 |
| 2023 | 1 | €1,128 | €1,128 |
Key figures and ratios
per financial year, computed from the annual accounts| Line | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| 36,842 | 42,217 | 43,121 | ||
| 24,356 | 30,868 | 33,563 | ||
| 5,090 | 897 | 22,934 | ||
| -135 | 30,883 | - | ||
| 65,442 | 51,012 | 25,677 | ||
| 80.8% | 78.7% | 57.7% | ||
| 5.19 | 7.03 | 3.06 | ||
| 0.24 | 0.27 | 0.73 | ||
| 23.8% | 42.9% | 91.0% | ||
| 19.2% | 33.7% | 52.5% | ||
| 22.37 | 16.53 | 30.80 |
A Belgian filing has no cash-flow statement. Cash flow is therefore an approximation, derived from the income statement. Investment is the acquisitions in the notes and, without them, the balance-sheet move.
Investments
fixed assets acquired| Item | 2025 | 2024 | 2023 |
|---|---|---|---|
| Tangible fixed assets | €5,090 | €897 | €22,934 |
| Financial fixed assets | €0 | - | - |
| €6,118 | €5,764 | €3,126 |
Source: notes to the 2023 to 2025 annual accounts (statement of fixed assets)
Insights on RERO
The operating result for 2025 is 16% lower than in 2024 and the lowest since 2023. It is the second fall in a row.
Debt's share of the balance-sheet total falls from 21.3% to 19.2%. Equity and debt are higher.
Board & ownership
Board
2 directors, since incorporationDirector
appointed by deed of 20-06-2023
term without a fixed end
listed in the 2025 annual accounts, filed on 29-07-2026
Director
appointed by deed of 20-06-2023
term without a fixed end
listed in the 2025 annual accounts, filed on 29-07-2026
- Signing authorityThe articles say who may bind the company, for example by signing a contract.
- Each director alonedeed of 20-06-2023
Mandates through the years
2 names, the dashed line is todayDANIELS, Reine
Director
Director
ENGELEN, Roy Hendrik
Director
Director
Board
Mandates as a list
- DANIELS, Reine
- Director, appointed by deed of 20-06-2023, still in office
- ENGELEN, Roy Hendrik
- Director, appointed by deed of 20-06-2023, still in office
Control
Capital
- Contribution
- €3,000
- Shares
- 30
- Contribution per share
- €100
- Equity per share
- €2,559 in 2025
- Source
- deed of 20-06-2023
Articles of association
deed of 20-06-2023 (in Dutch)- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimited
- Board ruleThese rules set how the board is made up, meets and takes decisions.
- At least 1 director
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- First Monday of June at 18:00
Shareholders
At incorporation
deed of 20-06-2023 ↗
- ENGELEN, Roy Hendrik 15 shares (50%) · €1,500
- DANIELS, Reine 15 shares (50%) · €1,500
Network & group
No group
RERO has no parent and no holdings in its annual accounts. RERO shares no director with another company.
Timeline
Timeline
8 events since 2023Filings
Financial
Establishments
2023202420252026
Deadline for the 2026 accounts: 31-07-2027
2026
Annual accounts 2025 filed NBBmicro format · 2 days before the deadline
2025
Weakest financial year net €18,238 ▼27.4% The net result drops to €18,238, the lowest from 2023 to 2025.
Registered in the Peppol Directory Reachable for e-invoices through 0208:0802826141
Annual accounts 2024 filed PDFmicro format · 31 days before the deadline
2024
Liquidity more than doubled current ratio 7.03 The current ratio rises from 3.06 to 7.03. Short-term debt falls from €12,472 to €8,463.
Annual accounts 2023 filed PDFabbreviated format · 78 days before the deadline
2023
IncorporationFounding capital of €3,000, 30 shares · Founders: ENGELEN, Roy Hendrik; DANIELS, Reine · Appointments: ENGELEN, Roy Hendrik (director) and DANIELS, Reine (director) · published on 20-06-20236 points ▸
- Registered office clause, Tessenderlosesteenweg 180, 3583 Beringen
- Director appointment, ENGELEN, Roy Hendrik
- Director appointment, DANIELS, Reine
- Founding capital, €3,000, 30 shares
- Founder, ENGELEN, Roy Hendrik
- Founder, DANIELS, Reine
- The deed holds 2 more points.
First establishment Tessenderlosesteenweg 180, Beringen
Financial milestones sit on the financial year-end date, not the filing date.
Sources: Publications in the Belgian Official GazetteFilings with the National Bank
History
Company details
Identity
- Enterprise number
- 0802.826.141
- VAT number
- BE 0802.826.141
- Peppol ID
- 0208:0802826141
- Other Peppol ID
- 9925:BE0802826141
- Legal form
- Private limited company
- Status
- Active, normal situation
- Founded
- 16-06-2023
- Financial year
- ends on 31 December
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- First Monday of June at 18:00deed of 20-06-2023 (in Dutch)
- Peppol
- Reachable since 21-12-2025Follow this company and you will hear the next morning if it leaves the Peppol register.
- Name
- RERO in Dutch
- Entity type
- Legal entity
- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimiteddeed of 20-06-2023 (in Dutch)
- Registered office clauseThe articles name the region of the registered office. The language of official documents depends on that region, among other things.
- “Vlaams Gewest”deed of 20-06-2023 (in Dutch)
Activities
NACEBEL 202586951
Physiotherapy main activity
- PurposeThe purpose describes the activities the company may carry out under its articles.
- “Het uitbaten van een kinesistenpraktijk,verstrekken van diensten op het gebied van fysische geneeskunde en aanverwante behandelingsmethoden…”deed of 20-06-2023 (in Dutch)
8 activities
- Het uitbaten van een kinesistenpraktijk,verstrekken van diensten op het gebied van fysische geneeskunde en aanverwante behandelingsmethoden;
- Het verstrekken van alle medische en paramedische zorgen zonder onderscheid,zoals ondermeer maar niet uitgezonderd,de fysio- en mechanotherapie,kinesitherapie,de manuele therapie,dry needling,echografie,de medische trainingstherapie,de motorische revalidatie,heil- en groepsgymnastiek,revalidatietherapie,orthopedagogie,cognitieve gedragstherapie,het inrichten van cursussen van conditiegymnastiek en alle andere therapie,alsook alle mogelijke consultancy- en onderwijsactiviteiten,dit alles in de meest ruime zin;
- De exploitatie van gezondheidscentra en multidisciplinaire groepspraktijken;
- Beweeg- en sportcoaching,alsook sportpsychologische assistentie;
- Het behandelen van mobiliteitsstoornissen,orthopedische manuele therapieën,lymfedrainage,sportkinesitherapie,babymassage,osteopathische behandelingstechnieken,alternatieve en/of klassieke geneeskunde,perinatale kinesitherapie,sportrevalidatie,taping,sportmedische testen,rugschooltraining,ademhalingstechnieken,inspanningstesten,lactaatmetingen,fitness,sportadvies,bikefitting,sportbegeleiding en alle met het kinesitherapieberoep aanverwante verenigbare disciplines en verband houdende activiteiten;
- Klein- en groothandel in voedingssupplementen,orthopedische en verzorgingsartikelen;
- De aan- en verkoop,het huren en verhuren van apparatuur,instrumenten en materialen,producten en begeleidende accommodaties die noodzakelijk of nuttig zijn voor de exploitatie van een kinesitherapeutische praktijk;
- Het besturen en leiden van vennootschappen,ondernemingen en verenigingen,en daartoe het uitoefenen van mandaten van bestuurder,zaakvoerder,beheerder;
Registered office and establishments
1 establishment| Establishment | Since | Unit number |
|---|---|---|
| Tessenderlosesteenweg 180 registered office 3583 Beringen | 16-06-2023 | 2.346.598.165 |
Buildings and parcels at the address
- Ground area
- 3,464 m²
- Buildings
- 258 m²
- Volume, LiDAR
- 293 m³
- Tallest building
- 7.4 m
Buildings to scale, each on its own parcel
Parcels
| Cadastral parcel | Area | Buildings | Height / floors |
|---|---|---|---|
| 71382D0524/00Y002 | 3,464 m² | 1 · 258 m² | 7.4 m |